PAREA
@pareascience.bsky.social
85 followers 46 following 71 posts
Advocating in Europe for modern, rational, safe, and ethically responsible integration of psychedelic-assisted therapies into mainstream health services.
Posts Media Videos Starter Packs
pareascience.bsky.social
Mental health conditions cause more years of ill-health than cancer, diabetes & heart disease combined, yet innovation has stalled. Join us 4 November in Brussels & online for our hybrid event, exploring how Europe can go from lagging to leading in mental health innovation. parea.eu/events/nov4
pareascience.bsky.social
The EMA’s updated guideline on depression treatment takes effect today, with a dedicated section on psychedelics. PAREA contributed >10 comments during consultation, many of which shaped the final text. See the revised guideline here: tinyurl.com/ema-gl
pareascience.bsky.social
Pain Alliance Europe (PAE), has launched an important EU-wide survey exploring the links between chronic pain, mental health, and self-management. The findings will inform advocacy efforts and shape better policies for people living with chronic pain across Europe.

lnkd.in/dv2vd7CC
pareascience.bsky.social
Buenos Aires will host LaPsyConf, an international conference on mental health, longevity, and well-being. Tadeusz Hawrot opens with Global Issues: Mental Health Indicators, Global Regulation, and Economic Impact. Get 10% off with code PAREA. Register: www.lapsyconf.com
pareascience.bsky.social
On Oct 1 in Lisbon, following the @psypaleu.bsky.social General Assembly, PAREA will join EU at @champalimaudf.bsky.social stakeholders for a full-day symposium focused on the ethical, regulatory & clinical dimensions of psychedelic-assisted care. Learn more & register: tinyurl.com/8h2jnup
pareascience.bsky.social
On this World Suicide Prevention Day, PAREA supports the call to change the narrative on suicide, moving from stigma and silence to openness, understanding, and support. Together, prevention is possible. @iaspinfo.bsky.social
pareascience.bsky.social
We’re pleased to support the upcoming Borealis Psychedelic Science Summit, a two-day scientific conference taking place in Stockholm on September 26–27, as a Community Partner. Learn more and register here: borealissummit.com
pareascience.bsky.social
The WHO just released two reports on mental health. They show more than 1B people live with a disorder, while governments’ spending has barely moved since 2017. Europe leads at $51.76 per person, the Americas just $6.86. Disorders keep rising, but investment hasn’t.
🔗 lnkd.in/dW_NU3VA
pareascience.bsky.social
PAREA is partnering with Inawe Foundation for Psymposium Madrid 2025, Oct 2–4. The conference features leading experts in mental health, neuroscience, and psychedelics, and our community receives 10% off tickets with code PSYMP0S1UM2025. More here: tinyurl.com/parea-psympo...
pareascience.bsky.social
The Dutch Medicines Evaluation Board will host a Pipeline Meeting on 5 Nov 2025, focusing on the regulatory development of psychedelics.

Pharmaceutical companies can apply to present and discuss psychedelic development challenges with Dutch regulators.
Deadline: 29 Aug tinyurl.com/meb-pipeline...
pareascience.bsky.social
Norway just took a big step in mental health: its regulator will reimburse off-label generic IV ketamine for treatment-resistant depression paired with psychotherapy. Backed by a positive HTA, years of protocolized use, and NORAAD’s €2.2m study. First in Europe. More: tinyurl.com/norway-ketam...
pareascience.bsky.social
PAREA has submitted its contribution to the EU’s EU4Health 2026 consultation. Our key message: mental health innovation must become a strategic and structural priority for EU health policy. The consultation is open until 30 September 2025. Our full contribution is available here: lnkd.in/dECfeG5d
pareascience.bsky.social
PsyPal just enrolled its first patient in the EU’s first multi-site trial of psilocybin therapy for palliative care beyond cancer.
100+ patients, 4 sites, 1 historic step for mental health in Europe. Read the full press release here: tinyurl.com/psypal-augus...
pareascience.bsky.social
Germany becomes the first EU country to approve compassionate use of psychedelic therapy. Patients who haven’t responded to conventional depression treatments can now access it at CIMH and the OVID Clinic. A major step toward broader access to psychedelic care in Europe! tinyurl.com/compassionat...
pareascience.bsky.social
We’re happy to welcome Irish Doctors for Psychedelic Assisted Therapy as the newest member of PAREA’s Community Supporters network. This fall, PAREA will join the Psychedelic Research Conference, co-hosted by IDPAT and Trinity College Dublin. More here: tinyurl.com/idpat
pareascience.bsky.social
A new expert commentary published on The Mental Elf outlines five priorities to advance psychedelic mental health care. Co-authored by leading voices across sectors, it reflects growing momentum. PAREA is pleased to have contributed input. Learn out more about it here: parea.eu/parea-news/i...
New expert commentary outlines five priorities to advance psychedelic therapies in mental health care — PAREA
A new expert commentary is outlining five priorities to advance psychedelic therapies in mental health care. Published on The Mental Elf—an online resource on mental health research— the piece follow...
parea.eu
pareascience.bsky.social
Big news: PAREA just received a €50K grant from Entheon Foundation to strengthen EU advocacy, push for more funding, and build capacity for psychedelic-assisted mental health treatments across Europe. Thanks to Entheon for backing this work!
Read more here: parea.eu/parea-news/e...
pareascience.bsky.social
PAREA is delighted to welcome Nico Gusac to our team as our new Communications Officer!
With a multidisciplinary background and a deep commitment to mental health, culture, and ethics, Nico is passionate about healing as a relational and systemic process, convinced that community is medicine.
pareascience.bsky.social
Today, the EU4Health Civil Society Alliance launched Health4Europe: a blueprint for the next EU Health Programme. As a proud member, PAREA endorses this call to keep health a top EU priority in the next MFF. Read the full proposal here: tinyurl.com/eu4healthblueprint
pareascience.bsky.social
On February 26, 2025, during the Psychedelics as Medicine conference in Reykjavik, Iceland, representatives from all Nordic psychedelic associations signed the Manifesto for the Nordic Psychedelic Network Initiative. Learn more in our latest guest article by Cecilie Byholt Endresen: bit.ly/3TOXmyg
pareascience.bsky.social
We’re proud to be representing the PsyPal project @psypaleu.bsky.social at Psychedelic Science, in Denver, and at the European Academy of Neurology Congress, in Helsinki!
pareascience.bsky.social
Compass Pathways released topline data from the first-ever Phase 3 trial of a classical psychedelic - COMP360 psilocybin - for treatment-resistant depression: significant improvements and no new safety concerns. Attention now turns to the larger COMP006 trial.
pareascience.bsky.social
PAREA is turning 3! 🎉

We’ve spent the past days in Denver at Psychedelic Science 2025 and now at the European Academy of Neurology @ean.org Congress in Helsinki connecting with peers and team members face-to-face.

Thanks to everyone who’s supported our journey — we’re just getting started.
pareascience.bsky.social
🧠 One week until #EAN2025 in Helsinki!
We'll be there 21–24 June with a booth in the Neurohood + a session at the Scientific Theatre.

Come learn about the evolving frontier of psychedelic innovation in neurology, and about EU trial PsyPal (@psypaleu.bsky.social)! tinyurl.com/ean-session